HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line*

Arin N. Graner, Justin E. Hellwinkel, Alex M. Lencioni, Helen J. Madsen, Tessa A. Harland, Paul Marchando, Ger J. Nguyen, Mary Wang, Laura M. Russell, Lynne T Bemis, Thomas J. Anchordoquy, Michael W. Graner

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Agents targeting HSP90 and GRP94 are seldom tested in stressed contexts such as heat shock (HS) or the unfolded protein response (UPR). Tumor stress often activates HSPs and the UPR as pro-survival mechanisms. This begs the question of stress effects on chemotherapeutic efficacy, particularly with drugs targeting chaperones such as HSP90 or GRP94. We tested the utility of several HSP90 inhibitors, including PU-H71 (targeting GRP94), on a primary canine lung cancer line under HS/UPR stress compared to control conditions. Methods: We cultured canine bronchoalveolar adenocarcinoma cells that showed high endogenous HSP90 and GRP94 expression; these levels substantially increased upon HS or UPR induction. We treated cells with HSP90 inhibitors 17-DMAG, 17-AAG or PU-H71 under standard conditions, HS or UPR. Cell viability/survival was assayed. Antibody arrays measured intracellular signalling and apoptosis profiles. Results: HS and UPR had varying effects on cells treated with different HSP90 inhibitors; in particular, HS and UPR promoted resistance to inhibitors in short-term assays, but combinations of UPR stress and PU-H571 showed potent cytotoxic activity in longer-term assays. Array data indicated altered signalling pathways, with apoptotic and pro-survival implications. UPR induction + dual targeting of HSP90 and GRP94 swayed the balance toward apoptosis. Conclusion: Cellular stresses, endemic to tumors, or interventionally inducible, can deflect or enhance chemo-efficacy, particularly with chaperone-targeting drugs. Stress is likely not held accountable when testing new pharmacologics or assessing currently-used drugs. A better understanding of stress impacts on drug activities should be critical in improving therapeutic targeting and in discerning mechanisms of drug resistance.

Original languageEnglish (US)
Pages (from-to)303-317
Number of pages15
JournalInternational Journal of Hyperthermia
Volume33
Issue number3
DOIs
StatePublished - Apr 3 2017
Externally publishedYes

Fingerprint

Unfolded Protein Response
Heat-Shock Proteins
Canidae
Cell Line
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
Drug Delivery Systems
tanespimycin
Cell Survival
Apoptosis
Adenocarcinoma of lung
Drug Resistance
Pharmaceutical Preparations
Shock
Lung Neoplasms
Neoplasms
Adenocarcinoma
Hot Temperature
glucose-regulated proteins

Keywords

  • Unfolded protein response
  • apoptosis
  • cell stress
  • heat shock
  • heat shock protein 90 inhibitor

Cite this

HSP90 inhibitors in the context of heat shock and the unfolded protein response : effects on a primary canine pulmonary adenocarcinoma cell line*. / Graner, Arin N.; Hellwinkel, Justin E.; Lencioni, Alex M.; Madsen, Helen J.; Harland, Tessa A.; Marchando, Paul; Nguyen, Ger J.; Wang, Mary; Russell, Laura M.; Bemis, Lynne T; Anchordoquy, Thomas J.; Graner, Michael W.

In: International Journal of Hyperthermia, Vol. 33, No. 3, 03.04.2017, p. 303-317.

Research output: Contribution to journalArticle

Graner, AN, Hellwinkel, JE, Lencioni, AM, Madsen, HJ, Harland, TA, Marchando, P, Nguyen, GJ, Wang, M, Russell, LM, Bemis, LT, Anchordoquy, TJ & Graner, MW 2017, 'HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line*', International Journal of Hyperthermia, vol. 33, no. 3, pp. 303-317. https://doi.org/10.1080/02656736.2016.1256503
Graner, Arin N. ; Hellwinkel, Justin E. ; Lencioni, Alex M. ; Madsen, Helen J. ; Harland, Tessa A. ; Marchando, Paul ; Nguyen, Ger J. ; Wang, Mary ; Russell, Laura M. ; Bemis, Lynne T ; Anchordoquy, Thomas J. ; Graner, Michael W. / HSP90 inhibitors in the context of heat shock and the unfolded protein response : effects on a primary canine pulmonary adenocarcinoma cell line*. In: International Journal of Hyperthermia. 2017 ; Vol. 33, No. 3. pp. 303-317.
@article{5bfb7eb7f7c4426d85d47a98a62bb92f,
title = "HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line*",
abstract = "Background: Agents targeting HSP90 and GRP94 are seldom tested in stressed contexts such as heat shock (HS) or the unfolded protein response (UPR). Tumor stress often activates HSPs and the UPR as pro-survival mechanisms. This begs the question of stress effects on chemotherapeutic efficacy, particularly with drugs targeting chaperones such as HSP90 or GRP94. We tested the utility of several HSP90 inhibitors, including PU-H71 (targeting GRP94), on a primary canine lung cancer line under HS/UPR stress compared to control conditions. Methods: We cultured canine bronchoalveolar adenocarcinoma cells that showed high endogenous HSP90 and GRP94 expression; these levels substantially increased upon HS or UPR induction. We treated cells with HSP90 inhibitors 17-DMAG, 17-AAG or PU-H71 under standard conditions, HS or UPR. Cell viability/survival was assayed. Antibody arrays measured intracellular signalling and apoptosis profiles. Results: HS and UPR had varying effects on cells treated with different HSP90 inhibitors; in particular, HS and UPR promoted resistance to inhibitors in short-term assays, but combinations of UPR stress and PU-H571 showed potent cytotoxic activity in longer-term assays. Array data indicated altered signalling pathways, with apoptotic and pro-survival implications. UPR induction + dual targeting of HSP90 and GRP94 swayed the balance toward apoptosis. Conclusion: Cellular stresses, endemic to tumors, or interventionally inducible, can deflect or enhance chemo-efficacy, particularly with chaperone-targeting drugs. Stress is likely not held accountable when testing new pharmacologics or assessing currently-used drugs. A better understanding of stress impacts on drug activities should be critical in improving therapeutic targeting and in discerning mechanisms of drug resistance.",
keywords = "Unfolded protein response, apoptosis, cell stress, heat shock, heat shock protein 90 inhibitor",
author = "Graner, {Arin N.} and Hellwinkel, {Justin E.} and Lencioni, {Alex M.} and Madsen, {Helen J.} and Harland, {Tessa A.} and Paul Marchando and Nguyen, {Ger J.} and Mary Wang and Russell, {Laura M.} and Bemis, {Lynne T} and Anchordoquy, {Thomas J.} and Graner, {Michael W.}",
year = "2017",
month = "4",
day = "3",
doi = "10.1080/02656736.2016.1256503",
language = "English (US)",
volume = "33",
pages = "303--317",
journal = "International Journal of Hyperthermia",
issn = "0265-6736",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - HSP90 inhibitors in the context of heat shock and the unfolded protein response

T2 - effects on a primary canine pulmonary adenocarcinoma cell line*

AU - Graner, Arin N.

AU - Hellwinkel, Justin E.

AU - Lencioni, Alex M.

AU - Madsen, Helen J.

AU - Harland, Tessa A.

AU - Marchando, Paul

AU - Nguyen, Ger J.

AU - Wang, Mary

AU - Russell, Laura M.

AU - Bemis, Lynne T

AU - Anchordoquy, Thomas J.

AU - Graner, Michael W.

PY - 2017/4/3

Y1 - 2017/4/3

N2 - Background: Agents targeting HSP90 and GRP94 are seldom tested in stressed contexts such as heat shock (HS) or the unfolded protein response (UPR). Tumor stress often activates HSPs and the UPR as pro-survival mechanisms. This begs the question of stress effects on chemotherapeutic efficacy, particularly with drugs targeting chaperones such as HSP90 or GRP94. We tested the utility of several HSP90 inhibitors, including PU-H71 (targeting GRP94), on a primary canine lung cancer line under HS/UPR stress compared to control conditions. Methods: We cultured canine bronchoalveolar adenocarcinoma cells that showed high endogenous HSP90 and GRP94 expression; these levels substantially increased upon HS or UPR induction. We treated cells with HSP90 inhibitors 17-DMAG, 17-AAG or PU-H71 under standard conditions, HS or UPR. Cell viability/survival was assayed. Antibody arrays measured intracellular signalling and apoptosis profiles. Results: HS and UPR had varying effects on cells treated with different HSP90 inhibitors; in particular, HS and UPR promoted resistance to inhibitors in short-term assays, but combinations of UPR stress and PU-H571 showed potent cytotoxic activity in longer-term assays. Array data indicated altered signalling pathways, with apoptotic and pro-survival implications. UPR induction + dual targeting of HSP90 and GRP94 swayed the balance toward apoptosis. Conclusion: Cellular stresses, endemic to tumors, or interventionally inducible, can deflect or enhance chemo-efficacy, particularly with chaperone-targeting drugs. Stress is likely not held accountable when testing new pharmacologics or assessing currently-used drugs. A better understanding of stress impacts on drug activities should be critical in improving therapeutic targeting and in discerning mechanisms of drug resistance.

AB - Background: Agents targeting HSP90 and GRP94 are seldom tested in stressed contexts such as heat shock (HS) or the unfolded protein response (UPR). Tumor stress often activates HSPs and the UPR as pro-survival mechanisms. This begs the question of stress effects on chemotherapeutic efficacy, particularly with drugs targeting chaperones such as HSP90 or GRP94. We tested the utility of several HSP90 inhibitors, including PU-H71 (targeting GRP94), on a primary canine lung cancer line under HS/UPR stress compared to control conditions. Methods: We cultured canine bronchoalveolar adenocarcinoma cells that showed high endogenous HSP90 and GRP94 expression; these levels substantially increased upon HS or UPR induction. We treated cells with HSP90 inhibitors 17-DMAG, 17-AAG or PU-H71 under standard conditions, HS or UPR. Cell viability/survival was assayed. Antibody arrays measured intracellular signalling and apoptosis profiles. Results: HS and UPR had varying effects on cells treated with different HSP90 inhibitors; in particular, HS and UPR promoted resistance to inhibitors in short-term assays, but combinations of UPR stress and PU-H571 showed potent cytotoxic activity in longer-term assays. Array data indicated altered signalling pathways, with apoptotic and pro-survival implications. UPR induction + dual targeting of HSP90 and GRP94 swayed the balance toward apoptosis. Conclusion: Cellular stresses, endemic to tumors, or interventionally inducible, can deflect or enhance chemo-efficacy, particularly with chaperone-targeting drugs. Stress is likely not held accountable when testing new pharmacologics or assessing currently-used drugs. A better understanding of stress impacts on drug activities should be critical in improving therapeutic targeting and in discerning mechanisms of drug resistance.

KW - Unfolded protein response

KW - apoptosis

KW - cell stress

KW - heat shock

KW - heat shock protein 90 inhibitor

UR - http://www.scopus.com/inward/record.url?scp=85006870160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006870160&partnerID=8YFLogxK

U2 - 10.1080/02656736.2016.1256503

DO - 10.1080/02656736.2016.1256503

M3 - Article

C2 - 27829290

AN - SCOPUS:85006870160

VL - 33

SP - 303

EP - 317

JO - International Journal of Hyperthermia

JF - International Journal of Hyperthermia

SN - 0265-6736

IS - 3

ER -